Corindus Vascular Robotics (CVRS) Reports In-Line Q4 EPS

Corindus Vascular Robotics (NYSE: CVRS) reported Q4 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $4.77 million.

For earnings history and earnings-related data on Corindus Vascular Robotics (CVRS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• NVE Corporation names new CEO and expands board to seven members